Home         Forums  

Go Back   Marrowforums > Treatments > Clinical Trials
Register FAQ Search Today's Posts Mark Forums Read

Clinical Trials Considering or participating in research studies

Reply
 
Thread Tools Search this Thread
  #1  
Old Thu Mar 29, 2018, 01:23 PM
Marrowforums Marrowforums is offline
Marrowforums.org
 
Join Date: Jul 2006
Posts: 857
ACH-4471 in trials for PNH treatment

Achillion Pharmaceuticals is sponsoring a tiny Phase II trial of ACH-4471, a new drug for the treatment of PNH.

ACH-4471 inhibits a specific molecule that is part of the complement process, and may reduce hemolysis.

ACH-4471 was recently approved in Europe for treatment of C3 glomerulopathy.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Learning About Clinical Trials and Finding Clinical Trials Marrowforums Clinical Trials 0 Wed Jun 3, 2015 05:10 PM
Need help with RCMD treatment (trials) Mantist Drugs and Drug Treatments 9 Sun Nov 17, 2013 02:08 AM
New Treatment Center Information Marrowforums Site Announcements 0 Sun Feb 17, 2008 04:53 PM
Interactive Treatment Center Map Marrowforums Site Announcements 0 Tue Jan 1, 2008 11:22 PM


All times are GMT -4. The time now is 11:58 PM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2018, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2018 Marrowforums.org